Nafamostat mesilate attenuates inflammation and apoptosis and promotes locomotor recovery after spinal cord injury

AIM: Spinal cord injury (SCI) leads to severe neural damage for which there is currently no effective treatment. Exploration of the neuroprotective effect among clinically approved drugs will speed up clinical translation of SCI. Nafamostat mesilate (NM) as a synthetic serine protease inhibitor has...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:CNS Neurosci Ther
Hlavní autoři: Duan, Hui‐Quan, Wu, Qiu‐Li, Yao, Xue, Fan, Bao‐You, Shi, Hong‐Yu, Zhao, Chen‐Xi, Zhang, Yan, Li, Bo, Sun, Chao, Kong, Xiao‐Hong, Zhou, Xin‐Fu, Feng, Shi‐Qing
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2018
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6489917/
https://ncbi.nlm.nih.gov/pubmed/29352519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12801
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky